Noninvasive diagnosis of renal osteodystrophy (literature review)
- Authors: Upolovnikova VS1, Romasheva EP1, Rubanenko OA1
-
Affiliations:
- Самарский государственный медицинский университет
- Issue: Vol 13, No 5-6 (2013)
- Pages: 75-78
- Section: Articles
- URL: https://bakhtiniada.ru/2410-3764/article/view/24805
- DOI: https://doi.org/10.17816/2072-2354.2013.0.5-6.75-78
- ID: 24805
Cite item
Full Text
Abstract
Keywords
About the authors
V S Upolovnikova
Самарский государственный медицинский университет
E P Romasheva
Самарский государственный медицинский университет
O A Rubanenko
Самарский государственный медицинский университет
References
- WORLD HEALTH ORGANIZATION: Burden of disease project. Available at http://www3.who.int/. Accessed September 2004
- KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney International (2009) 76, S3-S8 doi: 10.1038/ki.2009.189.
- Кузина Н.Ю., Орлова Г.М. Некоторые эффекты вторичного гиперпаратиреоза у больных с хронической болезнью почек. Нефрология и диализ - 2008 - Т.10, № 2. - с. 140-143.
- Ranjani N Moorthi, Sharon M Moe. Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney International, 2013.
- Koivula MK, Risteli L, Risteli J. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum. Clin Biochem 2012 45: 920-927.
- Milliner D.S., Zinsmeister A.R., Lieberman E., Landing B. Soft tissue calcification in pediatric patients with end-stage renal disease // Kidney Int.-1990-Vol.38, № 5.-P.931-936.
- Ganesh SK, Stack AG, Levin NW, et al: Association of elevated serum PO (4), Ca _ PO (4) product and parathyroid hormone with mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2113, 2001.
- Yenchek RH, Ix JH, Shlipak MG et al. Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 2012 7: 1130-1136.
- Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 2007 49: 674-681.
- Ambrus C, Almasi C, Berta K et al. Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol 2011 43: 475-482.
- Ranjani N Moorthi, Sharon M Moe. Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney International, 2013.
- Tilman B Drüeke and Ziad A Massy. Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression. Kidney International (2013) 83, 13-15.
- Bhattacharyya N, Chong WH, Gafni RI, Collins MT. Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab. 2012 Dec;23(12):610-8.
- Institute of Medicine. Dietary References Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. National Academy Press 1997.
- Wesseling-Perry K, Pereira RC, Wang H et al. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 2009 94: 511-517.
- Razzaque MS. Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant. 2009 Jan;24(1):4-7.
- Jean G, Bresson E, Terrat JC et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.Nephrol Dial Transplant 2009 24: 948-955.
- Middleton R.J., Parfrey P.S., Foley R.N. Left ventricular hypertrophy in the renal patient. Am. J. Soc. Nephrol. 2001 12:1079-84.
Supplementary files
